Copyright 2004 Japan Corporate News Network.
All Rights Reserved.
JCNN
September 21, 2004 Tuesday 1:06 AM Eastern Time
LENGTH: 102 words
BYLINE: Aki Tsukioka; Staff Writer, newsroom@japancorp.net
DATELINE: Tokyo, Japan

Japanese cosmetics company Noevir announced September 16 that it will establish the Noevir-Keio Research Laboratory within the School of Medicine at Keio University in Tokyo in October.

The lab will start a joint research project for amyotrophic lateral sclerosis [ALS]one of the incurable diseases with which Japan has 10,000 patients.

The new industry-academia joint research project will aim to develop anti-ALS agents and make it marketable as early as possible.

Although the disease's basic theory was established more than 130 years ago, a definitive treatment for ALS has yet to be discovered.